Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma

Esophageal adenocarcinoma (EAC) is the fastest growing cancer in the western world and the overall 5 year survival rate of EAC is below 20%. Most patients with EAC present with locally advanced or widespread metastatic disease, where current treatment is largely ineffective. Therefore, new therapeut...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Oncol
Main Authors: Hassan, Md Sazzad, Awasthi, Niranjan, Li, Jun, Williams, Fiona, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press 2018
Assuntos:
Original article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884213/
https://ncbi.nlm.nih.gov/pubmed/29475139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.01.022
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares